跳至主要内容
临床试验/ACTRN12621000633886
ACTRN12621000633886已完成2 期

Assessing the effectiveness of photo-dynamic therapy (PDT) for local prostate cancer by imaging, urinary proteomics and Circulating Tumour Cell (CTC) analysis, a randomized 3-month trial

ational Institute of Integrative Medicine0 个研究点目标入组 35 人开始时间: 2021年5月27日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
50 Years 至 80 Years(—)
性别
Male

入选标准

  • Group A: Men with biopsy proven primary prostate cancer, or local prostate cancer relapse after treatment
  • Group B: Men with primary prostate cancer, diagnosed by PSMA-PET or MRI scan
  • Group C: Men with metastatic prostate cancer

排除标准

  • Not planning other treatment or medical interventions, e.g. vaccinations during the 3 month trial period.
  • not able to provide consent

研究者

发起方
ational Institute of Integrative Medicine

相似试验